新华社基加利9月18日电（记者吉莉）第25批中国援卢旺达医疗队18日向卢旺达东方省基本戈医院捐赠 一批医疗器械。 捐赠仪式上，中国医疗队向卢方捐赠了电动手术台、无影手术灯、妇科检查床等设备。 卢旺达东方省恩戈马地区区长尼约纳吉拉·纳塔莉对中方捐赠表示衷心感谢。她说，中国长期以来在基 础设施、教育、医疗等领域给予卢旺达宝贵支持，显著改善了当地民生。基本戈医院长期得到中方在人 力、技术和设备等方面的支持，1992年与中方合作完成扩建，目前正稳步朝着建成一所完整教学医院的 目标迈进。 中国援卢医疗队队长王永祥介绍说，此次捐赠的物资主要用于手术室和妇产科，将有助于提升医院手术 能力，改善患者就医条件。据介绍，过去9个月，第25批医疗队共完成手术702台，接诊患者万余人次， 组织5次义诊和健康宣教活动，并开展12次学术与文化交流。 自1982年以来，中国已派出25批、共324名医务人员赴卢旺达开展医疗援助，分别在马萨卡医院和基本 戈医院开展日常诊疗，累计接诊72万余人次，实施手术4万余台，挽救超过1.6万名危重患者生命。 中国驻卢旺达大使高文棋在致辞中表示，数十年来，中卢医疗合作广泛深入、成果丰硕。中国曾援建基 本戈医 ...

Group 1 - Huazhong Securities has been approved to issue subordinate corporate bonds with a total face value of no more than 10 billion yuan [1] - Jinbei Automotive plans to invest 240 million yuan to establish an automotive industry investment fund focusing on electrification, intelligence, and low carbon [1] - Linyang Energy is expected to win a bid for a 244 million yuan metering equipment project from Southern Power Grid [1][2] Group 2 - Renfu Pharmaceutical's subsidiary has received drug registration certificates for two products, including a medication for acute hypotension [3][4] - Nanjing Steel plans to distribute a cash dividend of 0.1186 yuan per share [5][6] - Pairui Co. has signed a strategic cooperation agreement with Xi'an Power Electronics Research Institute to develop power devices [7][8] Group 3 - Haixing Electric is expected to win a bid for a 214 million yuan metering equipment project from Southern Power Grid [9][10] - Kuangda Technology is planning a change in control, leading to a continued suspension of its stock [11][12] - Samsung Medical is expected to win a bid for a 274 million yuan metering equipment project from Southern Power Grid [13][14] Group 4 - Jiukang Bio has obtained a medical device registration certificate for a specific diagnostic kit [15][16] - Hechuan Technology's minority shareholder plans to transfer a 13% stake in a subsidiary [17][18] - DiAo Micro has launched a new eUSB2 repeater product for various electronic applications [19][20] Group 5 - David Medical's electric surgical table registration application has been accepted [21][22] - Hangxin Technology plans to apply for a total of 280 million yuan in bank credit [23][24] - Liyuan Technology's non-independent director has resigned [25][26] Group 6 - Ningbo Construction's subsidiary has won a construction project bid worth 729 million yuan [27][28] - Huaren Pharmaceutical's subsidiary has received approval for a raw material drug [29][30] - Suwen Electric plans to distribute a cash dividend of 1 yuan per 10 shares [31][32] Group 7 - Solar Energy has received 1.692 billion yuan in renewable energy subsidies [33][34] - Wangli Security has obtained a patent for a new lock structure [35][36] - Zhejiang Energy's vice chairman has resigned due to age reasons [37][38] Group 8 - Beilu Pharmaceutical's subsidiary has passed GMP certification in Brazil [39][40] - Zhejiang Communications has a subsidiary that is expected to win a highway project bid [41][42] - Xinzhi Group has received a government subsidy of 11.1978 million yuan [43][44] Group 9 - Dong'an Power's engine sales in August increased by 3.44% year-on-year [45][46] - Baiyun Mountain's subsidiary has passed the consistency evaluation for two generic drugs [47][48] - Yipin Hong's subsidiary has received a drug registration certificate for a specific injection [49][50] Group 10 - Far East Holdings' subsidiary has won multiple contracts totaling 1.689 billion yuan [51][52] - Good Housekeeping's shareholder plans to reduce holdings by up to 3.5 million shares [53][54] - Guanghong Technology's shareholders have set a transfer price of 23.33 yuan per share [55][56] Group 11 - Keli Sensor plans to acquire 45% of Huahong Technology's shares for 122 million yuan [57][58] - Jianmin Group's furosemide oral solution has been approved for market launch [59][60] - Jinghua Laser's directors plan to reduce their holdings by up to 143,420 shares [61][62] Group 12 - Zhuyue Group is planning a share transfer that will change its controlling shareholder [63][64] - Terid has pre-bid for two projects totaling approximately 698 million yuan [65][66] - Zhonghuan Hailu is planning a change in control, leading to a continued suspension of its stock and convertible bonds [67][68] Group 13 - Great Wall Motors reported August sales of 115,600 vehicles, a year-on-year increase of 22.33% [69][70] - Guizhou Tire's controlling shareholder has committed not to reduce holdings for 12 months [71][72] - San Da Membrane's shareholder plans to reduce holdings by up to 1% of the company's shares [73][74] Group 14 - Chint Electric has decided to terminate the spin-off of its subsidiary for listing [75][76] - Jusaylong's shareholder plans to reduce holdings by up to 1% of the company's shares [77][78]

Group 1 - The company, David Medical, announced that it has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for its product, an electric surgical table [2] - The acceptance number for the product is: 20254028265 [2] - This development indicates a significant step in the regulatory process for the company's medical equipment [2]

戴维医疗（300314）(300314.SZ)公告，公司近日取得1项由浙江省药品监督管理局颁发的《受理通知 书》，相关产品名称为：电动手术台。 ...

Group 1 - The company, David Medical, announced on September 2 that it has received a "Notice of Acceptance" from the Zhejiang Provincial Drug Administration for its electric surgical table product [1] - The electric surgical table is designed to support high weight capacity in any position, catering to the variability of surgeries and different patient positions [1] - The modular design of the table surface allows it to be suitable for a wide range of surgical procedures [1]

Core Viewpoint - David Medical (300314.SZ) has recently obtained a "Acceptance Notice" issued by the Zhejiang Provincial Drug Administration for its product, an electric surgical table [1] Group 1 - The company has received regulatory approval for its electric surgical table [1]

戴维医疗公告称，公司于近日取得1项由浙江省药品监督管理局颁发的《受理通知书》，受理号为：械 受20254028265。本次申报产品为电动手术台，采用电动液压控制方式，通过微型按键开关控制器灵活 控制台面的各种运动，以满足手术所需的各种体位要求。上述医疗器械产品目前所处的审批阶段为注册 申请受理，后续所需的审批流程为技术审评、行政审批、制证。上述品种注册申请受理对公司近期业绩 不会产生影响，后续各阶段所需的时间和结果均具有一定的不确定性。 ...